Clinical Trials Browser

Rectal Neoplasms × Drug Combinations × Gastrointestinal × Clear all

NCT04389086 2022-09-06

PelvEx II

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms